On April 17, 2025, BSE Sensex closed 1.96% higher at 78,553.21, while Nifty50 jumped 1.77% to 23,851.65. Amidst the market volatility, stocks like Gensol Engineering, Sky Gold and Diamonds, Emcure Pharmaceuticals, and Kesoram Industries hit circuit limits, reflecting significant price movements. Check out the full list of stocks hitting circuit today.
Symbol | LTP | %chng | Price Band % | Volume(Lakhs) | Value(₹ Crores) |
IGIL | 353.3 | 4.99 | 5 | 33.73 | 117.76 |
WEBELSOLAR | 1,383.90 | -0.62 | 5 | 6.77 | 96.43 |
SKYGOLD | 351 | 5 | 5 | 22.25 | 77.75 |
EMCURE | 1,102.90 | 9.38 | 10 | 5.29 | 56.89 |
PANACEABIO | 522.95 | 5 | 5 | 8.17 | 42.66 |
Symbol | LTP | %chng | Price Band % | Volume(Lakhs) | Value(₹ Crores) |
CELLECOR | 52.85 | -6.04 | 20 | 152.94 | 75.71 |
TEMBO | 427.45 | -5 | 5 | 0.87 | 3.72 |
KESORAMIND | 3.15 | -5.12 | 5 | 54.35 | 1.71 |
GENSOL | 116.54 | -5 | 5 | 1.14 | 1.33 |
PARAGON | 69.6 | -4.98 | 5 | 1.22 | 0.85 |
On April 17, 2025, Emcure Pharmaceuticals share price ended 9.38% higher at ₹1,102.90. Emcure Pharmaceuticals share price reached a 52-week high of ₹1,577.50, and a 52-week low of ₹890.00.
On April 17, Tembo Global Industries share price ended 5% lower at ₹427.45. Tembo Global Industries share price reached a 52-week high of ₹905.00, and a 52-week low of ₹191.35. At the current price, Tembo Global Industries shares are trading at a price-to-earnings (P/E) ratio of 12.18x, based on its trailing 12-month earnings per share (EPS) of ₹18.19, and a price-to-book (P/B) ratio of 7.82, according to exchange data.
On April 17, Gensol Engineering share price ended 5% lower at ₹116.45. Gensol Engineering share price reached a 52-week high of ₹1,125.75, and a 52-week low of ₹116.45. At the current price, Gensol Engineering shares are trading at a price-to-earnings (P/E) ratio of 3.47x, based on its trailing 12-month earnings per share (EPS) of ₹33.85, and a price-to-book (P/B) ratio of 0.69, according to exchange data.
On April 17, Panacea Biotec share price ended 5% higher at ₹522.95. Panacea Biotec share price reached a 52-week high of ₹522.95, and a 52-week low of ₹112.70. At the current price, Panacea Biotec shares are trading at a price-to-earnings (P/E) ratio of -757.90x, based on its trailing 12-month earnings per share (EPS) of ₹-0.69, and a price-to-book (P/B) ratio of 10.12, according to exchange data.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Apr 17, 2025, 3:45 PM IST
Dev Sethia
Dev is a content writer with over 2 years of experience at Business Today, Times of India, and Financial Express. He has also contributed stories in Hindi for BT Bazaar and Khalsa Bandhan News Paper. A journalism postgraduate from ACJ-Bloomberg, Dev enjoys spending his spare time on the cricket pitch.
Know MoreWe're Live on WhatsApp! Join our channel for market insights & updates